UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055700
Receipt number R000063647
Scientific Title A Comparative Interventional Study on the Effect of Progress Visualization Based on Self-recording in Outpatient Rehabilitation Patients on the Continuation of Home-based Self-rehabilitation
Date of disclosure of the study information 2024/10/02
Last modified on 2025/04/04 09:56:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Impact of Monitoring Rehabilitation Progress on the Continuation of Home-based Rehabilitation

Acronym

Rehabilitation Progress and Continuation Study

Scientific Title

A Comparative Interventional Study on the Effect of Progress Visualization Based on Self-recording in Outpatient Rehabilitation Patients on the Continuation of Home-based Self-rehabilitation

Scientific Title:Acronym

RCT on Progress Visualization and Rehabilitation Continuation

Region

Japan


Condition

Condition

Orthopedic Disorders (Postoperative or Under Conservative Therapy)

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the impact of self-recording and progress visualization on the continuation of home-based self-rehabilitation in outpatient rehabilitation patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Whether or not home-based self-rehabilitation was continued (Assessment timing: 3 months after the start of the trial)

Key secondary outcomes

Changes in joint range of motion and muscle strength (Assessment timing: at the start of the trial and 3 months after)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

In the intervention group, patients self-record the number of voluntary rehabilitation sessions on a recording sheet, and a research assistant will follow up with the patients during weekly outpatient visits.
At the follow-up, a bar graph of the cumulative number of times will be created using Excel based on the recording paper.
This graph is intended to provide visual feedback on the patient's rehabilitation progress. The intervention period is one month, with follow-ups occurring once a week.

Interventions/Control_2

In the control group, patients will self-record the number of home-based rehabilitation sessions on a provided log sheet, but progress visualization (creating and providing graphs) will not be conducted.
The intervention period is 3 months, and during weekly outpatient visits, the research staff will review the rehabilitation records without providing any graphical feedback.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Patients attending Konan Medical Center for orthopedic disorders.
2.Patients who have undergone surgery for orthopedic disorders or are undergoing conservative therapy.
3.Age between 50 and 80 years at the time of consent.
4.Patients who have received instructions for home-based self-rehabilitation from an orthopedic surgeon and a physical therapist (PT) at Konan Medical Center.
5.Patients who are able to voluntarily consent to participate in this study.

Key exclusion criteria

1.Patients with Alzheimers disease, dementia, or other cognitive impairments requiring treatment
2.Patients with severe mental disorders requiring treatment, such as major depression or schizophrenia
3.Patients with severe comorbidities such as heart failure NYHA class III or IV, renal failure eGFR less than 30 mL per min per 1.73 square meters, or respiratory diseases predicted value less than 50 percent in lung function tests
4.Patients with systemic diseases such as rheumatoid arthritis that restrict movement
5.Patients with infections or other complications at the surgical site
6.Patients participating in other research studies that may interfere with this studys rehabilitation intervention
7.Any other patients deemed unsuitable by the study investigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yoshihiro
Middle name
Last name Muragaki

Organization

Kobe University

Division name

Graduate School of Medicine, Department of Biomedical Engineering

Zip code

650-0017

Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo

TEL

078-382-5342

Email

muragaki@people.kobe-u.ac.jp


Public contact

Name of contact person

1st name Kotaro
Middle name
Last name Tagawa

Organization

Graduate School of Kobe University

Division name

Graduate School of Medicine, Department of Biomedical Engineering

Zip code

650-0017

Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo

TEL

078-382-5342

Homepage URL


Email

233m107m@stu.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University

Institute

Department

Personal name

Kotaro Tagawa


Funding Source

Organization

Kobe University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Organization Name: Kobe University, Clinical and Translational Research Promotion Center, IRB Office

Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo

Tel

078-382-6669

Email

kainyu@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 10 Month 21 Day

Date of IRB


Anticipated trial start date

2024 Year 10 Month 21 Day

Last follow-up date

2025 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 10 Month 02 Day

Last modified on

2025 Year 04 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063647